Article
Clinical features and management of germline CEBPA-mutated carriers.
Leukemia research - 1 Mar 2024
Pan Lili, Li Yining, Gao Huiying, Lai Xiaolin, Cai Yuanhua, Chen Zhixiang, Li Xiaofan, Wang Shao-Yuan
Abstract excerpt
Familial acute myeloid leukemia (AML) pedigrees with germline CCAAT/enhancer-binding protein-α (CEBPA) mutation have been rarely reported due to insufficient knowledge of their clinical features. Here, we report two Chinese families with multiple AML cases carrying germline CEBPA mutations, one of which had 11 cases spanning four consecutive generations. Additionally, we collected clinical data of 57 AML patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
